Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00197067
Status:
COMPLETED
Last Update Posted:
2019-12-27
First Post:
2005-09-13
Brief Title:
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals Candidate Vaccines RTSSAS02D 05 mL Dose and RTSSAS02A 025 mL Dose Administered IM According to a 0 1 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2005-04-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-04-26
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-13
First Submit QC Date:
September 13 2005
Study First Post Date:
2005-09-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-26
Last Update Post Date:
2019-12-27
Last Update Post Date Type:
ACTUAL